DexCom

Youtube Subscribe

Open: 95.69 Close: 95.3 Change: -0.39

The best way to get informed about DexCom without reading hundreds of pages.

Are looking for the most relevant information about DexCom? Investor spend a lot of time searching for information to make investment decisions in DexCom. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about DexCom are: Dexcom, CGM, G7, stock, DexCom, glucose, system, and the most common words in the summary are: dexcom, stock, g7, dxcm, market, g6, price, . One of the sentences in the summary was: G7 system provides real-time glucose readings every five minutes.. Other searches related to this …

Concept Map

Semantic Network

Stock Summary

DexCom, Inc. focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems. The company provides its systems for use by people with diabetes, as well as for use. Dexcom G6.

Today's Summary

Dexcom stock (NASDAQ: DXCM) has seen a 17% fall in a month, compared to a 2% fall for the broader S&P500 index. Dexcom G7 is a continuous glucose monitoring (CGM) system. G7 system provides real-time glucose readings every five minutes.

Today's News

DexCom stock currently trades at $102 per share, about 36% higher than the level seen in early June 2022. The notable increase in DexComs revenues over recent quarters has contributed to the stock recovery. Dexcom G7 Mini overlays are a great option! Our medical grade material has 360 degree stretch so your overlay moves as you move. Our strong adhesive can last for 10+ days. Dexcom real-time CGM use is clinically proven to lower HbA1C, reduce hyper- and hypoglycaemia, and increase time in range 3-5. The proven accuracy of Dexcom ONE 1# allows people to make confident treatment decisions. Dexcom raised a total of $73.9M in its latest funding round. Investors of Dexcom include Canaan Partners, St. Louis Partners and Canaan Partners. DexCom stock rallies more than 50% in October to pace the S&P 500. On track to be the best October performer. Dexcom hiring Product Manager in San Diego, California, United States. Dexcom reported full-year 2022 revenues of $2.9B. Dexcom spent under $100 million on advertising in digital, print, and national TV in the last year. Use MediaRadar to stay current on new product launches for Dexcom. Dexcom stock (NASDAQ: DXCM) has seen a 17% fall in a month, compared to a 2% fall for the broader S&P500 index. In 2022, DexComs revenue was $2.91 billion, an increase of 18.84% compared to the previous years $2.45 billion. Dexcom G7 is a continuous glucose monitoring (CGM) system. G7 system provides real-time glucose readings every five minutes, as well as trend information, alerts for high or low glucose levels. Dexcom G6 has a sensor and transmitter that can easily be connected to any compatible Android or Apple phone to show your readings. The G7 combines the sensor and the transmitter into a single and much smaller device. Dexcom G7 is the most accurate* CGM system cleared by the FDA. The G7 can complete warmup within 30 minutes, whereas other CGM brands require up to an hour. Dexcom G7 CGM is here. With the help of Nick Jonas, Dexcom is introducing the new Dexcom CGM in a 2023 Super Bowl commercial. Dexcom trades on the NASDAQ under the ticker symbol DXCM. The total value of Dexcom stock (market capitalization) is $37.37B. The company has 387,871,796 outstanding shares. DexCom launches latest CGM sensor one in France. DexCom ONE continuous glucose monitoring (CGM) system has been launched in France for people with diabetes. Dexcom already has a prickless CGM monitor device that integrates with pumps.

Stock Profile

"DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices for specific and permitted use cases, including non-medical device applications, medical device data analysis, integrated continuous glucose monitoring systems (iCGM) secondary display alarms, active patient monitoring, and treatment decisions; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California."

Keywords

This document will help you to evaluate DexCom without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about DexCom are: Dexcom, CGM, G7, stock, DexCom, glucose, system, and the most common words in the summary are: dexcom, stock, g7, dxcm, market, g6, price, . One of the sentences in the summary was: G7 system provides real-time glucose readings every five minutes.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #dexcom #stock #g7 #dxcm #market #g6 #price.

Read more →

Youtube Subscribe

---